⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for zelboraf™

Every month we try and update this database with for zelboraf™ cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell LeukemiaNCT01711632
Hairy Cell Leuk...
Vemurafenib
18 Years - Memorial Sloan Kettering Cancer Center
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid CancerNCT01709292
Thyroid Cancer
Vemurafenib (Al...
Vemurafenib (Po...
Post Surgery - ...
18 Years - M.D. Anderson Cancer Center
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid CancerNCT01709292
Thyroid Cancer
Vemurafenib (Al...
Vemurafenib (Po...
Post Surgery - ...
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: